Pediatrix Medical Group, Inc. (MD)

Pediatrix Medical Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	174.22	165.39	-99.07	-60.41	66.34	130.96
Depreciation & Amortization	22.61	21.83	32.23	36.17	35.64	32.15
Stock-Based Compensation	19.07	18.05	11.87	12.32	16.13	18.97
Other Adjustments	52.46	27.65	183.99	169.62	32.39	-44.95
Change in Receivables	17.96	30.56	10.29	26.28	-5.54	-72.73
Changes in Accounts Payable	6.55	28.33	51.14	-11.92	0.42	21.33
Changes in Income Taxes Payable	7.5	-1.21	-5.04	-21.68	18.23	-2.29
Changes in Other Operating Activities	-7.53	-15.85	31.84	-4.31	19.33	30.32
Operating Cash Flow	258.71	271.09	206.57	137.33	166.94	76.74
Operating Cash Flow Growth	20.70%	31.23%	50.43%	-17.74%	117.55%	-62.50%
Capital Expenditures	-21.39	-18.46	-22.02	-33.33	-29.71	-32.25
Sale of Property, Plant & Equipment	-	-	-	-	-	24.73
Purchases of Investments	-29.1	-29.85	-64.55	-31.89	-17.35	-15.05
Proceeds from Sale of Investments	27.12	26.67	52.49	22.91	16.89	16.5
Payments for Business Acquisitions	-30.2	-23.2	-8.17	-6.67	-28.17	-29.93
Proceeds from Business Divestments	-	30	-	-	-	-
Other Investing Activities	0.75	-3.47	6.84	0.81	1.38	-19.42
Investing Cash Flow	-22.81	-18.3	-35.41	-48.18	-56.95	-53.07
Short-Term Debt Issued	-	-	235.5	470	830	-
Short-Term Debt Repaid	-	-	-235.5	-474	-826	-
Net Short-Term Debt Issued (Repaid)	-	-	0	-4	4	-
Long-Term Debt Issued	-	-	-	-	650	-
Long-Term Debt Repaid	-20.31	-18.75	-12.5	-12.5	-1,056	-759.85
Net Long-Term Debt Issued (Repaid)	-20.31	-18.75	-12.5	-12.5	-406.26	-759.85
Issuance of Common Stock	3.07	3.18	3.64	4.91	5.4	6.85
Repurchase of Common Stock	-106.57	-86.68	-1.7	-0.92	-88.51	-4.72
Net Common Stock Issued (Repurchased)	-103.5	-83.5	1.94	3.99	-83.12	2.13
Other Financing Activities	-2.1	-5.25	-3.92	-13.21	-2.18	-2.4
Financing Cash Flow	-129.09	-107.49	-14.49	-25.72	-487.55	-760.12
Net Cash Flow	106.8	145.3	156.68	63.43	-377.57	-736.45
Free Cash Flow	237.32	252.63	184.55	104	137.23	44.49
Free Cash Flow Growth	-6.06%	36.89%	77.46%	-24.22%	208.46%	-74.70%
FCF Margin	12.29%	13.20%	9.17%	5.21%	6.96%	2.33%
Free Cash Flow Per Share	2.80	2.96	2.21	1.27	1.63	0.52
Levered Free Cash Flow	161.66	161.28	-23.42	-111.97	-292.02	-579.62
Unlevered Free Cash Flow	175.21	174.2	20.98	-25.92	176.68	231.07

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q